http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102018698-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1fdc8fc5f3a3d562e4bd7bf54ecfbf9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2009-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7f1a5fb0c6424e7eb4a3dccee19b88b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3be3f683b163d44e776bd045ce853f73
publicationDate 2011-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102018698-A
titleOfInvention Compounds and methods for treating estrogen receptor-related diseases
abstract The present invention relates to compounds, pharmaceutical compositions and methods for regulating the function of estrogen receptor hER-α36, for preventing and/or treating diseases mediated by estrogen receptor hER-α36, preventing and/or treating bone Loosening, inducing cell death and/or inhibiting cell proliferation, and preventing and/or treating diseases related to abnormal proliferation of cells such as cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022099930-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013104263-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101941959-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110092770-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103204838-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022099931-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110054605-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109310666-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9221781-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108884049-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103204838-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020248923-A1
priorityDate 2008-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466865843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163882132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163986057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465619057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465770739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466997572

Total number of triples: 41.